Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $65.00 price target on the stock. JSPR has been the subject of several other reports. Royal Bank of Canada began coverage on Jasper Therapeutics in a […]
Piper Sandler started coverage on shares of Zura Bio (NASDAQ:ZURA – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $26.00 price target on the stock. Separately, Oppenheimer reaffirmed an outperform rating and set a $16.00 price target (down previously from $17.00) […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given a consensus recommendation of “Buy” by the eight research firms that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the […]
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) Director Amit Munshi acquired 159,744 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was bought at an average cost of $3.13 per share, for a total transaction of $499,998.72. Following the completion of the transaction, the director now directly […]
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) insider Michael Howell purchased 7,987 shares of the company’s stock in a transaction on Monday, April 22nd. The stock was acquired at an average price of $3.13 per share, with a total value of $24,999.31. Following the purchase, the insider now owns 7,987 shares of the company’s […]